SOURCE: annual_report_text (1).txt
CHUNK: 699 of 1106
SIZE: 600 characters
PREVIOUS: chunk_0698_annual_report_text (1).txt
NEXT: chunk_0700_annual_report_text (1).txt
------------------------------
2022: 308.8 EUR 
million): the revenue of Proton Therapy activities 
amounts to EUR 229.1 million (2022: EUR 218.8 million), showing a slow 
increase of 4.7% due to a slow backlog 
conversion in H1 as well as significant 
costs at completion increases following 
a high inflation; the revenue of Other Accelerators 
activities amounts to EUR 133.7 million 
(2022: EUR 88.5 million), showing a 
significant increase of 51.1% thanks to a 
good backlog conversion with a high 
delivery volume and a solid order intake 
in H1; === Page 131 ===
IBA Annual Report 2023 
128. revenues for the Dosimetry segm